Aromatase Inhibitors: The Secret Weapon Against Breast Cancer

How Aromatase Inhibitors Work

Aromatase inhibitors work by blocking the enzyme aromatase, which converts androgens into estrogens. This process reduces estrogen levels, which is crucial because many breast cancers grow in response to estrogen.

Popular Aromatase Inhibitors

Common aromatase inhibitors include anastrozole, letrozole, and exemestane. Each has been shown to reduce the risk of cancer recurrence and is generally well-tolerated, though they do have some side effects like joint pain and bone loss.

Comparing With Other Treatments

Compared to tamoxifen, aromatase inhibitors often offer better outcomes in reducing cancer recurrence. However, they are only active in postmenopausal women, so tamoxifen remains a valuable alternative for those who cannot tolerate aromatase inhibitors.

Frequently Asked Questions

Key Takeaways

Aromatase inhibitors are a powerful tool against breast cancer in postmenopausal women.

Related Articles

• What You Need to Know About Postmenopausal Hormone Receptor-Positive Breast Cancer
• The Battle Against Breast Cancer: Endocrine Therapy Explained
• Prevent Breast Cancer Recurrence: Effective Strategies You Need to Know
• Risk Factors You Didn't Know Affect Breast Cancer Treatment Outcomes

References